TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06011642

Intervention type: DIAGNOSTIC_TEST
Intervention: Diagnostisches Interview bei psychischen Störungen im Kindes- und Jugendalter, digitale Version (Kinder-eDIPS)
Description: The Kinder-eDIPS is a digital, structured interviews which assesses the most frequent psychological disorders. It exists in a parent and a child version. It can be delivered by trained clinicians and takes between 60 and 120 minutes.

Intervention type: DIAGNOSTIC_TEST
Intervention: Diagnostisches Interview bei psychischen Störungen im Kindes- und Jugendalter, digitale Version (Kinder-eDIPS)
Description: The Kinder-eDIPS is a digital, structured interviews which assesses the most frequent psychological disorders. It exists in a parent and a child version. It can be delivered by trained clinicians and takes between 60 and 120 minutes.
Study: NCT05507099

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Bone Marrow Aspirate, Lipoaspirate Concentrate
Description: Autologous Cell Therapy.

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Bone Marrow Aspirate, Lipoaspirate Concentrate
Description: Autologous Cell Therapy.
Study: NCT05932888

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: QLM3003
Description: 1%（10g∶0.1g）or 1.5%（10g∶0.15g）or 2%（10g∶0.2g）

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: QLM3003 Placebo
Description: 1%（10g∶0.1g）or 1.5%（10g∶0.15g）or 2%（10g∶0.2g）(matching corresponding study medication)
Study: NCT05556655

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Magnetic Stimulation
Description: Transcranial Magnetic Stimulation (TMS) is a noninvasive method for stimulating neurons (axons not cell bodies) in the brain.

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Transcranial Magnetic Stimulation
Description: Transcranial Magnetic Stimulation (TMS) is a noninvasive method for stimulating neurons (axons not cell bodies) in the brain.
Study: NCT05062096

Intervention type: OTHER
Group type: OTHER
Intervention: Blood samples
Description: Blood samples at each protocol visit, T and NK cell analysis

Intervention type: OTHER
Group type: OTHER
Intervention: Blood samples
Description: Blood samples at each protocol visit, T and NK cell analysis

Intervention type: OTHER
Group type: OTHER
Intervention: Blood samples
Description: Blood samples at each protocol visit, T and NK cell analysis

Intervention type: OTHER
Group type: OTHER
Intervention: Blood samples
Description: Blood samples at each protocol visit, T and NK cell analysis

Intervention type: OTHER
Group type: OTHER
Intervention: Skin biopsy
Description: Biopsy of the skin lesion (optional)

Intervention type: OTHER
Group type: OTHER
Intervention: Skin biopsy
Description: Biopsy of the skin lesion (optional)

Intervention type: OTHER
Group type: OTHER
Intervention: Skin biopsy
Description: Biopsy of the skin lesion (optional)

Intervention type: OTHER
Group type: OTHER
Intervention: Skin biopsy
Description: Biopsy of the skin lesion (optional)
Study: NCT05734261

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Airway Oscillation System
Description: After each methacholine dose administred, respiratory function will be measured by forced oscillation
Study: NCT06054386

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Attentional Bias Modification Training (ABMT)
Description: The ABMT is aimed to modify attentional bias for negative stimuli in social anxiety by deliberately inducing the participant's attention to positive or neutral stimuli. In the training, after a pair of facial stimuli (e.g., threatening-neutral, neutral-neutral) are presented, a left or right arrow appears in one of the location. Participants are instructed to press the button in the correct direction as quickly and accurately as possible.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: General Attention Control Training
Description: The general attention control training aimed to improve participants' general attention control ability by asking them to press a left or right arrow in the correct direction. The basic design of attention control training is the same as the ABMT, but the attention control training does not aim to alter the direction of attention toward or away from certain stimuli.
Study: NCT05571111

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FE 999302
Description: Subcutaneous injection as a single dose. 3 different doses

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FE 999302
Description: Subcutaneous injection as a single dose. 3 different doses

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FE 999302
Description: Subcutaneous injection as a single dose. 3 different doses

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ovitrelle
Description: Subcutaneous injection as a single dose. 250 µg (0.5 mL)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Novarel
Description: Subcutaneous injection as a single dose. 10,000 IU (1 mL)
Study: NCT06496451

Intervention type: OTHER
Intervention: Spinal tap for CSF collection
Description: A spinal tap will be done on you by your choice of bedside or in the interventional radiology (IR) suite in the Shands (Neuromedicine) hospital. This procedure will be done by trained technicians under medical supervision or the principal investigator. Local anesthesia will be used to numb the site of injection on your back. We plan to collect about 4 tablespoons of spinal fluid.

Intervention type: OTHER
Intervention: Venipuncture for blood sample
Description: a sample of blood (approximately 4-5 tablespoonfuls) will be collected
Study: NCT06265831

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hand-fan application to the face
Description: Hand fan application is one of the applications recommended in managing dyspnea in evidence-based guidelines. Hand fan application effectively reduces shortness of breath by stimulating cold airflow to the 2nd and 3rd trigeminal nerve branches, mucosa, and skin.
Study: NCT04824807

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Yoga
Description: The yoga classes included a progression of low-impact, modified poses, stretching and isometric exercises focused on the shoulders, arms, and chest, and meditation. Breathing and poses to drain the lymphatic system were incorporated throughout the yoga practice to assist with lymphatic flow.~Exercises: sitting down badrasana, ardha navasana, dhanurasan, setu bandhasana, Urdhva Dhanurasana, Urdhvamukha Svanasana, Virabhadrasana, Warrior Virasana, Supta Virasana, Surya Namaskar, Mayurasana, Padmasana, Bharadvajasana.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Clinical Pilates
Description: before starting the clinical Pilates exercise program, the patients were trained on Pilates exercises and postures. During training, the patients were taught how to create lumbopelvic stability (core stabilization), which is the basis for Pilates exercises, and spinal stabilization and appropriate posture techniques.~Exercises: cork screw, toy soldier, kleopatra, the saw,breast stroke preparation, swimming, diamond press - arm openings, scapula isolations, open book, scissors, shoulder bridge.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: An educational booklet
Description: Only educational booklets will be given to the control group

Intervention type: OTHER
Group type: OTHER
Intervention: An educational booklet
Description: Only educational booklets will be given to the control group

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: An educational booklet
Description: Only educational booklets will be given to the control group
Study: NCT05098080

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Hutrukin
Description: Hutrukin that binds the human cytokine IL-1α with high affinity and is an effective blocker of IL-1α biological activity. Hutrukin is a True Human™ therapeutic antibody. That is, the antibody was generated by a natural human immune response and was cloned directly from a human peripheral B lymphocyte. No in vitro affinity maturation or modifications have been made to improve its natural binding affinity. A true human antibody should be effectively non-immunogenic in humans and thus exhibit optimal activity and pharmacokinetics indistinguishable from native IgG1 immunoglobulin.

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo control for Hutrukin IV push.
Study: NCT05830760

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Myocardium biopsy
Description: The expression of SGLT2 on small myocardium specimens harvested during aortic valve replacement operation in patients with aortic stenosis

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Myocardium biopsy
Description: The expression of SGLT2 on small myocardium specimens harvested during aortic valve replacement operation in patients with aortic stenosis
Study: NCT04534751

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Fibrinogen + PCC
Description: Patients randomized to the intervention group will receive 4g of Fibryga and 2000 IU Octaplex will be released as part of the first and second MHP packs, if requested.~If a third MHP pack is required, and thereafter, FC will be administered if the fibrinogen level drops below 1.5-2.0 g/L at the discretion of the clinical team or based on conventional laboratory test results or viscoelastic methods.~Patients in both groups will otherwise receive identical MHP treatment packs (4 units of red blood cells \[RBC\] in pack 1 and 4 units of RBC and 1 pool of platelets in pack 2 (equivalent to 4 units).

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Frozen Plasma
Description: 4U FP will be released as part of the first and second MHP packs.~Patients in both groups will otherwise receive identical MHP treatment packs (4 units of red blood cells \[RBC\] in pack 1 and 4 units of RBC and 1 pool of platelets in pack 2 (equivalent to 4 units).~Patients randomized to the control group may receive FC if the fibrinogen level drops below 1.5-2.0 g/L at the discretion of the clinical team or based on conventional laboratory test results or viscoelastic methods. FC dosing in MHP packs 3 and above will be site-specific and at the discretion of the treating clinician.
Study: NCT06171893

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Wavy stress application
Description: The intervention consists of the application named Wavy. Wavy uses artificial intelligence and the user's feedback to detect stress increasingly more efficient over time. This provides not only real-time feedback on an individual's stress level but also helps the patient to calm down using music guided relaxation. It does so with a music filter, allowing the participant to listen to music where the stress level determines the quality of the music.~Thus, relaxing is rewarded by improving the experience. In this process, implicit learning is used to establish a habit of getting better at recognising increased stress levels and getting familiar with reducing stress levels more and more effectively.
Study: NCT04991714

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lactisole
Description: sweet taste inhibitor (decreases sweetness)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lactisole
Description: sweet taste inhibitor (decreases sweetness)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rebaudioside M
Description: Sweetener (increases sweetness)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rebaudioside M
Description: Sweetener (increases sweetness)

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sucrose
Description: 10% Sucrose corresponding to a regular soft drink

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sucrose
Description: 10% Sucrose corresponding to a regular soft drink

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sucrose
Description: 10% Sucrose corresponding to a regular soft drink

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sucrose
Description: 10% Sucrose corresponding to a regular soft drink
Study: NCT05696951

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Transamine 200mg iv
Description: In the intervention group, intravenous TXA (Transamine) 1000 mg dissolved in 100 mL 0.9% sodium chloride was administered intravenously within 10 minutes as a loading dose within the first 30 minutes at the end of the surgery. After the end of the loading dose, a maintenance dose of 120mg/hour TXA was infused in 500ml (60ml/hour) SF. The placebo group was given 100ml of saline in the first 30 minutes, followed by a maintenance dose of 60ml/hour of saline for 8 hours.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Transamine 200mg iv
Description: In the intervention group, intravenous TXA (Transamine) 1000 mg dissolved in 100 mL 0.9% sodium chloride was administered intravenously within 10 minutes as a loading dose within the first 30 minutes at the end of the surgery. After the end of the loading dose, a maintenance dose of 120mg/hour TXA was infused in 500ml (60ml/hour) SF. The placebo group was given 100ml of saline in the first 30 minutes, followed by a maintenance dose of 60ml/hour of saline for 8 hours.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Transamine 200mg iv
Description: In the intervention group, intravenous TXA (Transamine) 1000 mg dissolved in 100 mL 0.9% sodium chloride was administered intravenously within 10 minutes as a loading dose within the first 30 minutes at the end of the surgery. After the end of the loading dose, a maintenance dose of 120mg/hour TXA was infused in 500ml (60ml/hour) SF. The placebo group was given 100ml of saline in the first 30 minutes, followed by a maintenance dose of 60ml/hour of saline for 8 hours.
Study: NCT05573243

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: bonding strategies
Description: The universal adhesive can be bonded using 3 different bonding strategies. Therefore, three bonding strategies will be assigned for 3 arms: etch-and-rinse, selective enamel etching, self-etch

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: bonding strategies
Description: The universal adhesive can be bonded using 3 different bonding strategies. Therefore, three bonding strategies will be assigned for 3 arms: etch-and-rinse, selective enamel etching, self-etch

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: bonding strategies
Description: The universal adhesive can be bonded using 3 different bonding strategies. Therefore, three bonding strategies will be assigned for 3 arms: etch-and-rinse, selective enamel etching, self-etch
Study: NCT05656196

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Chinese herbal tea VGH-DESJS-1
Description: Chinese herbal tea VGH-DESJS-1.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Chinese herbal tea VGH-DESJS-1
Description: Chinese herbal tea VGH-DESJS-1.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Chinese herbal tea VGH-DESJS-1
Description: Chinese herbal tea VGH-DESJS-1.
Study: NCT05858983

Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: FT-001 Low Dose
Description: Comparison of different dosages of FT-001

Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: FT-001 Mid Dose
Description: Comparison of different dosages of FT-001

Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: FT-001 High Dose
Description: Comparison of different dosages of FT-001
Study: NCT06515288

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nutrition Goes To School (NGTS) Program Intervention Package
Description: The NGTS Program intervention package in this project consists of four components:~1. A comprehensive Nutrition Education to improve healthy eating, physical activity, and hygiene-sanitation practices.~   This is a weekly interactive and fun nutrition and health promotion with different kinds of activities.~2. Healthy School Canteen to improve the availability of healthy food in school. This is an effort to strengthen the school canteen referring to the 4 Pillars of a Healthy School Canteen, including School Commitment and Management, Human Resources, Facilities and Infrastructure, and Food Quality.~3. School Garden. This is a gardening activity as a form of school garden as a media for nutrition education, character building, and contribute to supply vegetables during cooking class sessions in school.~4. Entrepreneurship nutrition. Entrepreneurship nutrition aims to foster entrepreneurial potential and skills among school members in providing healthy food at school.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nutrition Education Capacity Building for Teachers and Management
Description: The intervention schools will receive Nutrition Education Capacity Building for Teachers and School Management, before the above four NGTS components is implemented in the respective school. Three representatives from each school will be invited to attend a 5-day training that include knowledge on adolescent nutrition and health issues, as well as skills in implementing the NGTS Program.
Study: NCT05749016

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: inetetamab with pertuzumab and paclitaxel/carboplatin (TCbIP) regimen
Description: Inetetamab (Cipterbin) is a newly marketed anti-HER2 monoclonal antibody with amino acid modified Fc region and enhanced antibody-dependent cellular cytotoxicity (ADCC) effect. There was no robust evidence evaluating the combination of inetetamab with pertuzumab and neoadjuvant chemotherapy (paclitaxel + carboplatin) in the neoadjuvant setting. This study aimed to evaluate the efficacy and safety of inetetamab + pertuzumab+paclitaxel + carboplatin (TCbIP) as a neoadjuvant chemotherapy regimen in the treatment of patients with locally advanced HER2-positive breast cancer.
Study: NCT05637983

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: US-guided femoral puncture vs Fluoroscopy-guided puncture
Description: US-guided femoral puncture and Perclose ProGlide®/Prostyle implantation compared to Fluoroscopy-guided puncture and Perclose ProGlide®/Prostyle in TAVR

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: US-guided femoral puncture vs Fluoroscopy-guided puncture
Description: US-guided femoral puncture and Perclose ProGlide®/Prostyle implantation compared to Fluoroscopy-guided puncture and Perclose ProGlide®/Prostyle in TAVR
Study: NCT05287815

Intervention type: BEHAVIORAL
Intervention: training/observation
Description: In the study, elderly individuals who met the sampling criteria and accepted to participate in the study were 30 in the experimental group and 30 in the control group, using the stratified randomization method to control and balance the effects of age (65-75 years, 76 and over) and gender (female and male) variables. It will be planned to be an elderly individual. Computer-assisted randomization, which is one of the simple randomization methods, was assigned to the groups according to the determined.

Intervention type: BEHAVIORAL
Intervention: training/observation
Description: In the study, elderly individuals who met the sampling criteria and accepted to participate in the study were 30 in the experimental group and 30 in the control group, using the stratified randomization method to control and balance the effects of age (65-75 years, 76 and over) and gender (female and male) variables. It will be planned to be an elderly individual. Computer-assisted randomization, which is one of the simple randomization methods, was assigned to the groups according to the determined.
Study: NCT04646382

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Garlic and onion concentrate
Description: Garlic extract concentrate (equivalent to 2 garlic cloves) and onion extract concentrate (equivalent to 1 onion).

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Garlic and onion concentrate
Description: Garlic extract concentrate (equivalent to 2 garlic cloves) and onion extract concentrate (equivalent to 1 onion).

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Control
Description: Microcrystalline cellulose

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Control
Description: Microcrystalline cellulose
Study: NCT06088589

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mismatch negativity
Description: Event related potentials are compared between frequent and infrequent speech sounds (i.e., ba vs da).
Study: NCT06467695

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BIOPAC Stimsola
Description: Transcranial Electrical Stimulator

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: BIOPAC Stimsola Sham (zero amps)
Description: Transcranial Electrical Stimulator set to 0 amps
Study: NCT06417970

Intervention type: DIAGNOSTIC_TEST
Intervention: Shoulder Proprioception, Palmar Touch Sensation and Psychometric Parameters
Description: Shoulder Proprioception: Proprioception will be measured with isokinetic device. The measurement reference angles are 30° and 60°.~Palmar Touch Sensation: Palmar tactile sensation will be measured with the Semmes-Weinstein Monofilament.~Psychometric Parameters: Athlete Psychological Strain Questionnaire, Tampa kinesiophobia questionnaire
Study: NCT04668690

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mitoxantrone Hydrochloride Liposome Injection
Description: Drug: Liposomal mitoxantrone hydrochloride (20 mg/m2) administered as an intravenous infusion on day 1 of each 28-day cycle.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Chidamide
Description: Drug: Chidamide tablet (30 mg) is given to the patients p.o. 30 minutes after breakfast, twice per week with 3-day intervals.
Study: NCT06305663

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Bausch + Lomb (kalifilcon A) Myopia Control Soft (Hydrophilic)
Description: Bausch + Lomb (kalifilcon A) Myopia Control Soft (Hydrophilic)

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: CooperVision MiSight (omafilcon A/60%) Myopia Control one day Soft Contact Lens
Description: CooperVision MiSight (omafilcon A/60%) Myopia Control one day Soft Contact Lens
Study: NCT05689359

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine
Description: Hydroxychloroquine will be administered at 600 mg po BID for 3 days prior to starting chemotherapy, continued during the course of chemotherapy, and for 7 days after chemotherapy.
Study: NCT05959928

Intervention type: DEVICE
Intervention: Continuous wearable thermometer placed on patient's armpit to monitor body temperature remotely
Description: The HaH team will place Viture Device on the patient's armpit and train the patient and/or caregiver. They will ask to complete control STMs between 3 and 6 times a day on the same arm where the Viture Device is placed and record the measuring data in the Home data collection notebook (HDCN)
Study: NCT05768646

Intervention type: BEHAVIORAL
Intervention: Neuropsychological instruments
Description: Neuropsychological instruments assessing cognitive (including counterfactual abilities), behavioural and psychopathological features

Intervention type: BEHAVIORAL
Intervention: Neuropsychological instruments
Description: Neuropsychological instruments assessing cognitive (including counterfactual abilities), behavioural and psychopathological features